multidrug-resistant organisms

multidrug-resistant organisms

antimicrobial resistance, such as in methicilin-resistant Staphylococcus aureus and vancomycin-resistant enterococcis.

mul·ti·drug-re·sis·tant or·gan·isms

(mŭl'tē'drŭg-rē-zis'tănt ōr'găn-izmz)
Bacteria and other microorganisms that have developed resistance to many antimicrobial drugs (e.g., methicillin/oxacillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and penicillin-resistant Streptococcus pneumoniae).
References in periodicals archive ?
Second, although CP-CRE has been primarily identified from urban areas, these multidrug-resistant organisms can be introduced into rural areas by patients with exposure to health care in higher CP-CRE-prevalence areas, resulting in local transmission.
Community acquisition of multidrug-resistant organisms [MDROs] is increasing, not just within referral centers but also community hospitals.
SAN DIEGO -- Nearly half of nursing home residents harbored multidrug-resistant organisms on their skin, results from a large multicenter surveillance study showed.
Intensive-care units (ICUs) are a source of multidrug-resistant organisms, owing to the indiscriminate usage of broad-spectrum antimicrobial drugs.
Objective: To determine the impact of using colistin for multidrug-resistant organisms in neonates.
Multidrug-resistant organisms detected in refugee patients admitted to a university hospital, Germany, June -December 2015.
Formal hospital-based antimicrobial stewardship programs promote the appropriate use of antimicrobials (including antibiotics), which improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
Multidrug-resistant organisms are an increasing threat to healthcare worldwide.
The acquisition provides Roche with GeneWEAVE's Smarticles technology, an innovative class of molecular diagnostics that quickly identifies multidrug-resistant organisms (MDROs) and assesses antibiotic susceptibility directly from clinical samples, without the need for traditional enrichment, culture or sample preparation processes.
Their use has been associated with adverse NICU outcomes, including increased risks of necrotizing enterocolitis, late-onset sepsis, and death in infants with birth weights below 1,500 g, as well as an increase in multidrug-resistant organisms, he noted.
INTRODUCTION: Selection of empiric antibiotics for urinary tract infections (UTIs) has become more challenging because of the increasing rates of multidrug-resistant organisms especially multi drug resistant Enterobacteriaceae (MDRE) mostly ESBLs and Carbapenemases.
Patients infected with these multidrug-resistant organisms (MDROs) typically have increased mortality, increased hospital length of stay, and higher hospital costs than patients infected with susceptible organisms.

Full browser ?